Lazard Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 21 to 30 of 5828 Results

March 10, 2026
France

Jimmy announces €80m in new funding and enters a new phase of development to decarbonise industry

$92.8 Million

March 10, 2026
Belgium

Aedifica and Cofinimmo reach agreement to unite and create Europes leading healthcare REIT

$13.8 Billion

March 06, 2026
Brazil, France

EMS Group and Sanofi sign strategic sales agreement to support Medley’s next phase of growth in the Brazilian generics market

Undisclosed

March 04, 2026
France, United States

Pasqal, a Global Leader in Neutral Atom Quantum Computing, to Go Public via Business Combination with Bleichroeder Acquisition Corp. II

$2.6 Billion

March 04, 2026
United States

Peak Rock Capital Affiliate Signs Definitive Agreement to Sell Spatial Business Systems to Enverus, a Blackstone company

Undisclosed

March 02, 2026
Switzerland, United Kingdom

Recommended Cash Offer for Beazley by Zurich

$11 Billion

February 27, 2026
United States

Anthology, Inc. Announces Emergence From Chapter 11 Bankruptcy, Positioning the Company for Accelerated Growth

$1.9 Billion

February 27, 2026
Denmark, United Kingdom

The LEGO Group to acquire LEGO® Discovery Centres and LEGOLAND® Discovery Centres from Merlin Entertainments

$270.3 Million

February 24, 2026
United States

Arcline Investment Management to Acquire Hydraulics International, Inc.

Undisclosed

February 23, 2026
United States

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

$1.7 Billion